Texas, Florida, Georgia, North Carolina, Tennessee, Alabama, Mississippi, Louisiana, and Arkansas categorically excluded anti-obesity medications from Medicaid as of Q1 2026
In vitro and in vivo treatment of JMF4073 eliminates WT-Bcr-Abl-32D CML cells
Biochemical evaluations Venous blood samples were drawn at 7 am after 12-hour overnight fasting from an antecubital vein at day 0 and day 7 of the study
The semaglutide group showed a significantly improved Kansas City Cardiomyopathy Questionnaire clinical summary score and a longer 6-min walking distance from baseline (21.5 m and 1.2 m in the semaglutide and placebo groups, respectively, intergroup difference 20.3 m, 95% CI 8.632.1 m), compared with that in the placebo group despite the relatively short observation period of 52 weeks
Yes, we offer Semaglutide-based treatments, including Wegovy, depending on patient eligibility and clinical evaluation